For decades now, scientists have hypothesized that a flare-up of EBV may somehow be triggering the onset of MS. Now, a new study, led by researchers at the University of California San Francisco (UCSF ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

Ebvallo is one of a series of rare disease treatments recently turned back by the FDA amid shifting guidance that has ...

Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that members of ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Naked mRNA administration in the testes rescues sperm function, demonstrating a potential therapeutic approach for genetic male infertility.

The House Oversight Committee released recordings of last week's depositions with former President Bill Clinton and former ...

Disturbing images released in the Epstein files showing passages from Nabokov’s infamous novel written on bodies exemplify a world where women and girls are treated as objects for consumption.